Literature DB >> 19589767

Assessing the impact of lifestyle modification education on knowledge and behavior changes in gastroesophageal reflux disease patients on proton pump inhibitors.

Kristen Finley1, Martin Giannamore, Marialice Bennett, Laura Hall.   

Abstract

OBJECTIVES: To assess patients' knowledge of gastroesophageal reflux disease (GERD) lifestyle modifications and to identify patients' behaviors associated with GERD management before and after an educational intervention.
METHODS: The study was conducted at five indigent health centers in Columbus, OH, from January to May 2007. A total of 30 adult patients with GERD receiving proton pump inhibitor (PPI) therapy were assessed. In both the control and intervention groups, a pretest consisting of 23 questions assessed patients' knowledge regarding GERD and lifestyle modifications. A presurvey consisting of eight questions assessed patients' current behaviors associated with GERD management using both lifestyle modifications and PPIs. The intervention group also received approximately 10 minutes of education on lifestyle modifications. A posttest and postsurvey were given 8 to 12 weeks after the initial session to both groups. Main outcome measures included change in test score for patients in the control versus intervention groups. Outcomes measured on the pre- and postsurvey included source of heartburn information/education, smoking status, trigger foods eaten weekly, frequency of monthly heartburn episodes, and PPI adherence.
RESULTS: The average change in test scores was 1.33 and 2.73 in the control and intervention groups, respectively (P = 0.11; two-sample t test). The frequency of monthly heartburn episodes increased postsurvey in the control group; however, the frequency of monthly episodes decreased in the intervention group. For the presurvey, no patients reported ever having received GERD education from a pharmacist. For the postsurvey, all 15 patients in the intervention group stated that they had received education from a pharmacist.
CONCLUSION: The intervention group patients had higher mean change in test scores compared with the control group, although this difference did not reach statistical significance. The failure to achieve statistical significance may have resulted from the small sample size. The pharmacist-patient interaction improved patient knowledge and some behaviors made in GERD management and symptom reduction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19589767     DOI: 10.1331/JAPhA.2009.08004

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  3 in total

Review 1.  The Quality of Care for Gastroesophageal Reflux Disease.

Authors:  Rena Yadlapati; Lara Dakhoul; John E Pandolfino; Rajesh N Keswani
Journal:  Dig Dis Sci       Date:  2016-12-27       Impact factor: 3.199

2.  The Reflux Improvement and Monitoring (TRIM) Program Is Associated With Symptom Improvement and Weight Reduction for Patients With Obesity and Gastroesophageal Reflux Disease.

Authors:  Rena Yadlapati; John E Pandolfino; Olga Alexeeva; Dyanna L Gregory; Meredith R Craven; David Liebovitz; Abbey Lichten; Erin Seger; Moira Workman; Nora St Peter; Jenna Craft; Bethany Doerfler; Rajesh N Keswani
Journal:  Am J Gastroenterol       Date:  2017-10-10       Impact factor: 10.864

3.  Assessment of Patient Knowledge and Perceptions of Pharmacogenomics Before and After Using a Mock Results Patient Web Portal.

Authors:  Tien M Truong; Elizabeth Lipschultz; Keith Danahey; Emily Schierer; Mark J Ratain; Peter H O'Donnell
Journal:  Clin Transl Sci       Date:  2019-09-28       Impact factor: 4.689

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.